What's new

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 3, Status: Authorised

Jun 2, 2025 - 15:00
 0
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

PRIME: priority medicines

Next Article

List of medicines currently in PRIME scheme

Related Posts

Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0